Can You Invest in Anthropic Pre-IPO? Everything You Need to Know.

Anthropic, the Claude maker, is highlighted as a nearly $400 billion private AI company that investors can access indirectly before an IPO through AGIX, ARKVX, or DXYZ. The article notes each vehicle’s Anthropic exposure, including AGIX at 2.6% and ARKVX at 2.96%, but emphasizes that these funds carry high fees, ranging from 0.99% to 2.75% plus additional expenses. Overall, the piece is a constructive overview of pre-IPO AI exposure rather than a new company-specific catalyst.

Analysis

The real market signal is not “access to Anthropic” but the repricing of private AI exposure inside public wrappers. These vehicles are effectively high-beta proxies on late-stage venture marks, so incremental capital is likely to chase the same small set of AI winners already crowded in public portfolios: semis, hyperscalers, and AI infrastructure. That creates a second-order effect where the public market keeps underwriting the private market via NVIDIA, Microsoft, Alphabet, Amazon, Broadcom, and TSM, even though the private-company economics are still opaque.

DXYZ is the cleanest retail expression of this theme, but it is also the most vulnerable to mark-to-market compression because the portfolio is concentrated, thinly disclosed, and already trading as a momentum vehicle rather than a fundamentals vehicle. If the next private funding round for a flagship name comes in below the implied marks, the downside will likely show up first in the closed-end funds before it contaminates the broader AI complex. The timing matters: near-term performance can stay disconnected from intrinsic value for months, but any IPO delay or secondary-clearing event could catalyze a sharp reset.

The consensus is underestimating fee drag and overestimating diversification. Paying 250-350 bps to own a basket that is still dominated by a handful of venture marks only makes sense if you expect a very large, very fast re-rating in one of the underlying private names; otherwise, the hurdle rate is punishing. The better expression for most portfolios is still the ecosystem trade: own the pick-and-shovel public beneficiaries and avoid paying venture-like fees for venture-like risk.

Key Decisions for Investors

• Long NVDA / MSFT / AVGO as the cleaner AI infra expression versus private-market wrappers; target 3-6 months, with upside driven by continued capex pull-through and lower idiosyncratic mark risk.
• Short DXYZ on rallies or buy puts into strength; the trade is attractive if the market starts discounting stale private marks or if IPO timing slips, with a 1-3 month catalyst window.
• Avoid initiating new capital in ARKVX unless you specifically want venture-style illiquidity; the fee burden makes it a low-expected-value hold unless a single underlying private name rerates sharply over 12+ months.
• Pair long AGIX / short DXYZ for a relative-value expression: AGIX offers more liquidity and a larger public-asset base, while DXYZ has higher concentration and more mark-risk. Use a 3-6 month horizon.
• If you want exposure to the AI supply chain rather than venture marks, use TSM and AMZN as lower-volatility complements to the semis; this is the cleaner way to participate if private AI IPOs stay delayed.